# Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy

> **NCT02097446** · PHASE3 · UNKNOWN · sponsor: **Genewel Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Genital Diseases, Female

## Interventions

- **DEVICE:** Guardix-FL
- **DEVICE:** Interceed

## Key facts

- **NCT ID:** NCT02097446
- **Lead sponsor:** Genewel Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097446, "Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02097446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*